Murdoch Childrens Research Institute
🇦🇺Australia
- Country
- 🇦🇺Australia
- Ownership
- Holding
- Established
- 1986-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.mcri.edu.au
Evaluation of Full Versus Fractional Doses of COVID-19 Vaccines Given as a Booster in Adults in Australia - Mongolia, Indonesia, Australia Coronavirus (MIACoV).
Phase 3
Terminated
- Conditions
- COVID-19
- Interventions
- First Posted Date
- 2022-02-08
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 13
- Registration Number
- NCT05228730
- Locations
- 🇦🇺
Royal Children's Hospital, Melbourne, Victoria, Australia
Intranasal Heparin Treatment to Reduce Transmission Among Household Contacts of COVID 19 Positive Adults and Children
Phase 2
Active, not recruiting
- Conditions
- COVID-19
- Interventions
- First Posted Date
- 2022-01-24
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 506
- Registration Number
- NCT05204550
- Locations
- 🇦🇺
The Northern Hospital, Epping, Victoria, Australia
Clinical Hypnosis and Home Blood Pressure Monitoring in Children With Neurofibromatosis Type 1
Not Applicable
Completed
- Conditions
- Blood PressureHypertensionNeurofibromatosis 1
- First Posted Date
- 2022-01-19
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 54
- Registration Number
- NCT05196854
- Locations
- 🇦🇺
Murdoch Children's Research Institute, Parkville, Victoria, Australia
Methylphenidate in Childhood Apraxia of Speech
Phase 2
Recruiting
- Conditions
- Childhood Apraxia of Speech
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 24
- Registration Number
- NCT05185583
- Locations
- 🇦🇺
Murdoch Children's Research Institute, Parkville, Victoria, Australia
Is Medicinal Cannabis an Effective Treatment for Tourette Syndrome in Adolescents? a Pilot Study
Phase 1
Completed
- Conditions
- Tourette Syndrome in Adolescence
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 10
- Registration Number
- NCT05184478
- Locations
- 🇦🇺
Royal Children's Hospital / Murdoch Children's Research Institute, Parkville, Victoria, Australia
Investigating COVID-19 Vaccine Immunity in Children in the Melbourne Infant Study of BCG for Allergy and Infection Reduction
Phase 4
Completed
- Conditions
- COVID-19Vaccine ReactionImmunization; Infection
- First Posted Date
- 2021-12-23
- Last Posted Date
- 2023-02-09
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 51
- Registration Number
- NCT05168709
- Locations
- 🇦🇺
Melbourne Children's campus, Parkville, Victoria, Australia
Low Dose Multi-Nut Oral Immunotherapy in Pre-schoolers with a Multi-Nut Allergy
Not Applicable
Active, not recruiting
- Conditions
- Allergy, Nut
- First Posted Date
- 2021-09-20
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 12
- Registration Number
- NCT05049512
- Locations
- 🇦🇺
Murdoch Children's Research Institute, Parkville, Victoria, Australia
Diagnosis of Respiratory Viruses in Children With Rhinoswab Junior
Not Applicable
Completed
- Conditions
- COVID-19SARS CoV 2 Infection
- First Posted Date
- 2021-09-14
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 339
- Registration Number
- NCT05043623
- Locations
- 🇦🇺
Shidan Tosif, Parkville, Victoria, Australia
Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia
Phase 4
Recruiting
- Conditions
- Febrile Neutropenia
- Interventions
- First Posted Date
- 2021-07-02
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 312
- Registration Number
- NCT04948463
- Locations
- 🇦🇺
Royal Children's Hospital, Melbourne, Victoria, Australia
Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Children
Phase 4
Recruiting
- Conditions
- InfectionPediatric Infectious DiseaseComplicated Urinary Tract Infection
- Interventions
- First Posted Date
- 2021-05-06
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 452
- Registration Number
- NCT04876131
- Locations
- 🇦🇺
Women and Children's Hospital, Adelaide, South Australia, Australia
🇦🇺Monash Health, Melbourne, Victoria, Australia
🇦🇺Royal Children's Hospital, Parkville, Victoria, Australia